共 181 条
[1]
Rossin-Amar B(2000)Vaginal dryness in the menopausal woman (physiological and psychological aspects) Gynecol Obstet Fertil 28 245-249
[2]
Berman JR(1999)Female sexual dysfunction: anatomy, physiology, evaluation and treatment options Curr Opin Urol 9 563-568
[3]
Berman LA(2002)Hormon receptors in breast cancer: Racial differences in distribution and survival Breast Cancer Res Treat 73 45-59
[4]
Werbin TJ(2008)Arimidex, tamoxifen, alone or in combination (ATAC) trialists’ group. effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial Lancet Oncol 9 45-53
[5]
Goldstein I(2006)Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors Ann Oncol 17 584-587
[6]
Joslyn SA(2004)Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial J Clin Oncol 22 4261-4271
[7]
Forbes JF(1998)Life after breast cancer: understanding women’s health- related quality of life and sexual functioning J Clin Oncol 16 501-514
[8]
Cuzick J(2003)Arzneimittelkommission der Deutschen Ärzteschaft 2003. Hormontherapie im Klimakterium. Therapieempfehlungen Arzneiverordnung in der Praxis 3 19-26
[9]
Buzdar A(2007)Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of the North American Meno-pause Society Menopause 14 168-182
[10]
Kendall A(2008)Estrogen and progestogen use in post- menopausal women: July 2008 position statement of the North American Menopause Society Menopause 15 584-603